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Bone marrow-derived mesenchymal stem cells (BM-MSCs) can be induced to differentiate into myogenic
cells. Despite their potential, previous studies have not been successful in producing a high percentage of
cardiac-like cells with a muscle phenotype. We hypothesized that cardiac lineage development in BM-MSC is
related to cell passage, culture milieu, and enrichment for specific cell subtypes before and during
differentiation. Our study demonstrated that Lin− BM-MSC at an intermediate passage (IP; P8–P12)
expressed cardiac troponin T (cTnT) after 21 days in culture. Cardiac TnT expression was similar whether IP
cells were differentiated in media containing 5-azacytidine+2% FBS (AZA; 14%) or 2% FBS alone (LS; 12%)
and both were significantly higher than AZA+5% FBS. This expression was potentiated by first enriching for
CD117/Sca-1 cells followed by differentiation (AZA, 39% and LS, 28%). A second sequential enrichment for
the dihydropyridine receptor subunit α2δ1 (DHPR-α2) resulted in cardiac TnT expressed in 54% of cultured
cells compared to 28% of cells after CD117/Sca-1+ enrichment. Cells enriched for CD117/Sca-1 and subjected
to differentiation displayed spontaneous intracellular Ca2+ transients with an increase in transient frequency
and a 60% decrease in the transient duration amplitude between days 14 and 29. In conclusion, IP CD117/
Sca-1+ murine BM-MSCs display robust cardiac muscle lineage development that can be induced
independent of AZA but is diminished under higher serum concentrations. Furthermore, temporal changes
in calcium kinetics commensurate with increased cTnT expression suggest progressive maturation of a
cardiac muscle lineage. Enrichment with CD117/Sca-1 to establish lineage commitment followed by DHPR-
α2 in lineage developing cells may enhance the therapeutic potential of these cells for transplantation.
© 2010 Elsevier Ltd. All rights reserved.
1. Introduction
Bone marrow-derived mesenchymal stem cells (BM-MSCs) ex-
hibit neurogenic, chondrogenic, adipogenic, osteogenic, and myogen-
ic properties under specific differentiating conditions in vitro.
Although these cells have contributed to improvement in overall
cardiac performance in studies of myocardial regeneration, the
mechanisms responsible for their therapeutic effects are not well
established. BM-MSCs are characterized as a small percent of lineage
negative (Lin−) adherent cells, and their myogenic lineage potential is
highly dependent on the enrichment for specific markers following
harvesting. Published results have shown that further enrichment of
Lin− cells for the CD117 and Sca-1 membrane surface markers may
improve BM-MSC ability to differentiate into cardiomyocytes [1-5].
Furthermore, cell surface markers such as CD117 change over time [2,
6] and from passage to passage in cultured cells. Thus, we hypothesize
that in murine BM-MSC, differentiation into cardiomyocytes is
dependent on cell passage and the potential for differentiation is
greater in early passage cells (P≤12) compared to late passage cells
(P≥20).
Previous studies indicate that there is no well-defined and
consistent myogenic differentiation method. Some methods involve
the use of 5-azacytidine (AZA), a methyltransferase inhibitor.
Although this reagent induces myogenic development [7-9], it has
limited use in human cell therapy. Other differentiation protocols that
inducemyogenic commitment in BM-MSC include the use of TGF-beta
[6] and neonatal or adult cardiomyocyte co-cultures [10-13]. A recent
report on human embryonic stem cells (hESC) demonstrated that
hESC cardiomyocyte differentiation increased when the cells were
cultured in serum-free media compared to 20% serum in the media
[14]. Thus, we also propose to evaluate BM-MSC differentiation in low
serum (LS) media and compare it to AZA treatment.
We demonstrate here for the first time that CD117/Sca-1
enrichment following passage 10 in Lin− murine BM-MSC results in
increased sarcomeric protein expression and spontaneous calcium
transients that change over time in culture when differentiated in low
serum. Furthermore, we show that a subsequent second enrichment
for the dihydropyridine receptor subunit α2δ1 (DHPR-α2) and cell
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replating induces a greater expression of cardiac TnT expression than
with CD117/Sca-1 enrichment alone. Thus, we defined specific steps
that allow an enhanced differentiation of BM-MSC into
cardiomyocytes.
2. Materials and methods
2.1. Animals
Mice were housed in the Biological Resources Laboratory at UIC
(AAALAC accredited) and maintained in accordance with the Guide
for the Care and Use of Laboratory Animals (National Research
Council, revised 1996). Experimental protocols were approved by the
Institutional Animal Care and Use Committee (IACUC) at UIC.
2.2. Bone marrow mesenchymal stem cell (BM-MSC) characterization
and culture
Bone marrow was isolated from FVB.Cg-Tg(GFPu)5Nagy/J mice
(Jackson Laboratory) as previously described [15]. Tibia and femur
bones were stripped of muscle and placed in ice-cold PBS+2% FBS.
The epiphyseal ends were removed and the bones were centrifuged at
4000×g for 1 min in a microfuge tube. The bone marrow cells were
suspended in ice-cold PBS+2% FBS, passed through a 70-μm filter and
counted with a hemocytometer.
Filtered bone marrow cells were suspended in PBS+2% FBS+
0.1 g/L phenol red and enriched for lineage negative (Lin−) cells using
the SpinSep system(StemCell Technologies). The cellswere incubated
with Murine Progenitor Enrichment Cocktail (anti-CD5, anti-CD45R,
anti-CD11b, anti-Gr-1, anti-TER119, and anti-7/4; Stem Cell Technol-
ogies) on ice for 30 min and, after washing, incubated with dense
particles on ice for 20 min. The cells were layered on density medium,
centrifuged at 1200×g for 10 min, and the layer of cells at the density
medium/PBS interface was collected, washed, and counted.
Enriched bone marrow cells were seeded on tissue culture-treated
plates at a density of 0.1×106 cells/cm2 in murine Mesencult media
(Stem Cell Technologies) with 100 U/ml penicillin, 100 μg/ml
streptomycin, and 0.25 μg/ml amphotericin B added. The media
were changed after 48 h and adherent cellsweremaintained in culture
with twice weekly media changes. After 4 weeks the confluent cells
were detached with trypsin and split 3:1. Lin−MSCs were character-
ized for surface antigens using flow cytometry. Antibodies were
obtained from BD Pharmingen unless otherwise noted. Cultured cells
were detached with trypsin and incubated with 1 μl mouse Fc block
(1:50 dilution; clone 2.4G2, rat anti-mouse CD16/CD32) for 5 min on
ice. Cells were then incubated with 1 μl fluorescent-conjugated
antibodies (1:50 dilution) for 1 h on ice, washed, and analyzed.
The following mouse monoclonal antibodies were used: anti-
CD45-Cy5 (clone 30-F11), anti-Sca1-PE (clone E13-161.7), anti-
Sca1-Cy5 (clone D7; eBioscience), anti-CD34-PE (clone RAM34),
anti-CD90.1-PE (clone HIS51), anti-CD117(cKit)-PE (clone 2B8), anti-
CD105-biotin (clone MJ7/18; eBioscience). Those treated
with biotinylated antibodies were washed and incubated 20 min
at room temperature with 1 μl streptavidin–PE or streptavidin–Cy5.
Control sampleswere treatedwith immunoglobulin of the appropriate
isotype. Cells were analyzed in a (FACS) Calibur flow cytometer or in a
Beckman Coulter FC500 equipped with one (Calibur) or two
lasers (Beckman) for multiparametric and multicolor analysis,
including a 488-nm argon laser for measurement of forward
light scatter (FSC) and orthogonal scatter (SSC), and three to five
colors.
2.3. BM-MSC cardiomyocyte differentiation
BM-MSCs were plated (BD Falcon slides 354112 and Bioptech T-
dish 0420041500B) at a density of 8000 cells per well for early
passage cells (EP: P0–P2). All intermediate passages (IP: P8–P12) and
late passage (LP: P20 and above) cells were plated at a density of 3000
cells per well (4 cm2). Cells were allowed to attach to the plate by
culturing them for 24 h in Mesencult with supplements. After
adhering, cells were treated with one of five differentiating media
for 19–21 days (Fig. S1). AZA-treated cells were cultured with 1.2 μM
AZA in Eagle's MEM with 2% FBS for 72 h (Sigma: 5-azacytidine,
A2385, MEM, M0643 with 2.2 g sodium bicarbonate Invitrogen:
Certified Fetal Bovine Serum 16000-044). Low serum (LS)-treated
cells were cultured in Eagle's MEM with 2% FBS for 72 h. Cells were
also treated for 72 h with AZA alone and AZA with 5% serum. After
72 h, the media in the four AZA and/or LS groups were replaced every
2 to 3 days using MEM with 5% FBS and 5 μg/ml of insulin and
transferrin, 5 ng/ml of sodium selenite (Sigma: ITS, I1884 prepared as
recommended). A fifth group of cells was treated with MEM and 5%
FBS for the entire 19–21 days.
2.4. CD117/Sca-1 FACS analysis and enrichment
Following the differentiation period, cells were detached with
0.25% trypsin and incubated in FACS buffer (PBS with 2 mM EDTA and
0.25% BSA) with 1 μl anti-mouse IgG (Sigma: M0284, Fc block, 1:50
dilution) for 5 min on ice. Cells were then incubated with 1 μl
fluorescent-conjugated antibodies for Sca-1 (Bioscience: PE-Cy5 Ly-
6A/E 155981-81) and CD117 (BD Pharmingen: PE anti-mouse CD117
clone 2B8) for 1 h on ice, washed and analyzed. EP, IP, and LP cells
were analyzed for the presence of CD117 and Sca-1 and their results
are shown in Figs. S2A, B, and C, respectively. Although EP cells
exhibited the highest percentage of CD117/Sca-1+ cells compared to
IP and LP in our initial FACS analysis, we were unable to maintain
them as adherent cells in culture and therefore unable to assess the
potential of enriched cells from EP to differentiate and express cTnT.
LP cells although adherent after differentiation were negative for
CD117/Sca-1. Thus, we focused on the IP cell cultures which were
both adherent and contained sufficient CD117/Sca-1+ cells to assess
the potential for myogenic development. IP cells at P8 were analyzed
and enriched for CD117 and Sca-1 and cultured in Mesencult with
supplements. The expanded enriched cells (P10) were analyzed a
second time for the presence of CD117 and Sca-1 at the time of
differentiation and their FACS results are shown in Fig. S2D.
2.5. Immunofluorescent staining
Differentiated cells were stained for cardiac-specific Troponin T,
cardiac isoform Ab-1 (cTnT; Thermo Scientific MS-295-P0). The cells
were fixed with 2% paraformaldehyde for 20 min. We used horse
serum (5%) diluted in 0.1% Tween in PBS for blocking and
permeabilization for 45 min. Additional blocking with avidin and
biotin agents (Vector Labs, SP2001) was performed for 15 min each.
The primary cTnT was mixed with ready to use ultra Ab diluent
(Thermo Scientific, TA-125-UD, in a ratio of 1:200) and incubated
overnight at 4 °C. Biotinylated horse anti-mouse IgG (Vector Labs BA-
2001) was used as the secondary (1 h at RT, 1:250), and streptavidin
Alexa Fluor 555 or 633 conjugate (Invitrogen: S21381,
S21375,1:1000) was used for fluorescent detection (15 min at room
temp). After washing, cells were mounted with DAPI (Vector
Laboratories, Inc). For the isotype controls, we used IgG1 (R&D
Systems: MAB 002, 1:200). For DHPR-α2 staining, we used the same
procedure described above except that DHPR-α2 (ABR-Thermo
Fisher: MA3-921, 1:300) was used as the primary antibody.
2.6. DHPR-α2 enrichment of differentiated cells
After 26 days in culture, differentiated cells were lifted from the
plate with enzyme-free dissociation buffer (Gibco: 1752). Cells were
washed and re-suspended in a buffer mixture of 50% MEM and 50%
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FACS buffer. Cells were incubated for 90 min with the primary
antibody (ABR-Thermo Fisher: mouse anti-DHPR-α2, MA3-921) at a
concentration of 3 μl per 2×106 cells and placed on ice. Cells were
washed with the MEM buffer mixture and incubated for 1 h with the
secondary antibody (goat anti-mouse-IgG1 Cy5, Jackson Immuno
Research, PA No115-175-205) at a concentration of 3 μl per 2×106
cells on ice. Cells were washed, re-suspended, filtered (70 μm), and
FACS selected for DHPR-α2-positive cells. DHPR-α2 enriched cells
were plated at the same density as the originally differentiated cells
(3000 cells per cm2) and cultured for an additional 30 days. In a
separate experiment we added two control groups, one in which we
left the differentiated cells in culture for a total of 56 days and a
second in which we lifted the cells at day 26 and replated (3000 cells
per cm2) them for an additional 30 days. Thus, we could examine the
effects of both length of time in culture and lifting/replating the cells
on cTnT expression.
2.7. Intracellular calcium (Ca2+) measurements
Differentiated cells plated in 0.17 mm thick Bioptechs Delta T
dishes and incubated with MEM and 5% FBS media and a calcium-
sensitive dye (Fluo-4/AM, Invitrogen: F1420, 5 μM) .The dye was
prepared by dissolving 50 μg of fluo-4/AM in 50 μl of DMSO and 50 μl
of 20% Pluronic F-127 and 400 μl of Tyrode's salt solution [16] (Sigma:
T2145, with 1 g of sodium bicarbonate and pH set to 7.4 for 15 min at
room temperature). Thereafter, cells werewashed and incubatedwith
newMEMmedia and allowed to rest for 15min for de-esterification of
the dye. For viewing, the media was replaced with Tyrode's salt
solution. Calcium cycling cells were identified and selected for line
scan analysis (Zeiss LSM 510). The sampling time of the scan was
between 3.7 and 7.8 ms per line depending on the cycling rate of the
selected cell. Fluo-4/AMwas excited at 488 nm and the emission was
collected above 515 nm. The parameters extracted from the generated
curves were (1) Ca2+ transient frequency in Hertz, (2) Ca2+ transient
duration at 50% amplitude in milliseconds, TD50, and (3) Ca2+
transient duration at 90% amplitude in milliseconds, TD90.
2.8. cTnT-positive cell count and morphology
For positive cTnT cell count, fields of view within a slide were
randomly selected throughout the slide where cells were present.
Nucleus (DAPI staining) and cTnT (Alexa Fluor 555) images were
taken for each field with a Sony camera (DSC-H9). All images were
originally stored in bit map format and filtered utilizing ImageJ (NIH.
gov) for cell counting. The percentage of cTnT-positive cells was
obtained after comparing the number of positive cells with the
number of nucleus in a field.
For area measurements, fields of view were randomly selected
throughout the slide where cTnT-positive cells were present. Nuclei
(DAPI staining) and cTnT (Alexa Fluor 633) images were taken for
each field with a Zeiss confocal microscope with the cTnT color set to
green. Only cells aligned with the surface of the focal plane (those
having a defined nucleus) were measured. We used the analyze
particles tool from ImageJ (NIH software) tomeasure the cell area. The
average areas and the standard deviations at each of the time points
measured were divided by the average area of cells at day 5 to
compare cell area growth.
2.9. RT-PCR and cDNA sequencing
Total RNA was obtained from IP CD117/Sca-1-enriched cells
differentiated in 2% FBS at days 5, 15, 20 and 26 and adult cardiac
tissue using the Trizol® reagent (Gibco: No 15596) protocol for
suspended cells (BM-MSCs) and tissue protocol for the adult heart. The
RNA eluate was reverse transcribed using 5 μl of RNA and 200 U of M-
MLV RT reverse transcriptase and random hexamers (Invitrogen: No
8080127). PCR was performedwith Taq DNA Polymerase (Fermentas:
No. EP0402) and gene-specific primers 18 to 27 nucleotides in length.
The total PCR volumewas 50 μl, with 1 μl of the amplified cDNA, 1×PCR
buffer, 0.2 mM of dNTP, 2 mM of MgCl2, 2.5 U of Taq DNA polymerase,
and 0.4 μM of primer (see sequences below). PCR products were size-
fractionated by 2% agarose gel electrophoresis. The primer sequences
were as follows: for DHPR-α2 (forward) GGC CGG ATC CGC AAT TGA
TCC TAA TGG and (reverse) GAA GGC TGC AGA TCAT TGC AGT ATTC;
for cTnT (forward) TGC ACT TTG GAG GGT ACATC and (reverse) GTC
TTC ATT CAG GTG GTC GA; for cTnI (forward) GCT CCT CTG CCA ACT
ACCGA and (reverse) CAA CGA GTC CTCA GAA CGCG; for GATA-4
(forward) GAA CCT GAA TAA ATC TAA GACGC and (reverse) TCT GAG
TGA CAGGAG ATG CATA; and for GAPDH (forward) TAT GAC AAT GAA
TAC GGCT and (reverse) CTC CTG TTA TTA TGG GGG.
2.10. Fluo4/AM-loaded BM-MSCs in the presence of nifedipine
and cadmium
DHPR-α2-enriched cells were loaded with Fluo-4/AM and
incubated with Tyrode's salt solution. Initial video recordings of
Ca2+ cycling were taken while the cells were in Tyrode's salt and
electrically stimulated with a 5-ms pulse at 80 V and a frequency of
1.0 Hz. After 10 s, 40 μM nifedipine (Sigma: No. 7624) dissolved in
Tyrode's solution was applied drop wise while removing the original
Tyrode's with a peristaltic pump. The video recorded continuously
during the test; however, the light sourcewas periodically removed to
reduce fluorescence bleaching. Similarly, confocal line scans of
selected calcium cycling cells were taken (166 samples per second)
at different time periods during the nifedipine application. The
transient amplitude TA [(ΔF= Fmax− Fmin)/ F0] was calculated,
where F is the amplitude value after background subtraction and F0
is the minimum value of the first calcium cycle. An additional video
recording was made of DHPR-α2-enriched cells previously loaded
with Fluo-4/AM after application of 100 μM CdCl2 (Fisher Scientific:
C9-100) dissolved in Tyrode's salt solution.
2.11. Statistical data analysis
Values are presented as means±SEM and n is the number of
experiments. The significant differences between groups were
evaluated using SigmaStat (Systat Software Inc.). Groups with
unequal variances were analyzed using the Kruskal–Wallis Test, and
post hoc multiple comparisons between groups were performed with
Dunn's method. For experiments where only two sets of data were
compared, we used the Mann–Whitney rank sum test method. A
result of pb0.05 was considered statistically significant.
3. Results
3.1. BM-MSC flow cytometry and passage selection
In preparation for our experiments, MSCs were analyzed by flow
cytometry for the presence of various surface antigens after negative
lineage selection and following two different passages in culture.
Negative selection for the lineage markers CD5, CD45R, CD11b, Gr-1,
TER119, and 7/4 resulted in a cell population containing CD34 (3%),
CD 90.1 (34%), CD105 (23%), CD117 (43%), and Sca-1 (21%). Passage 4
Lin− adherent BM-MSC exhibited an increased Sca-1 and CD105
population (91% and 60%, respectively) while CD34-, CD90.1-, and
CD117-positive cells were low. Passage 17 BM-MSC continued to be
strongly Sca-1 positive but CD117 low. There was a dramatic increase
in CD34 by passage 17 so that 80% of the cells were positive for this
antigen. These data confirm the changing characteristics of MSC in
culture and further underscore the importance of FACS analysis and
enrichment for specific cell surface receptors prior to beginning
interventions with these cells. Previous studies have shown that a
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small percentage of BM-MSCs differentiate into cardiac-like cells.
Thus, we set up a series of experiments aimed at increasing the cTnT-
positive cell percentage by evaluating culture milieu and enrichment
for specific cell markers in IP cells before differentiation. In the first
series of experiments, we determined whether BM-MSC passage
selection would influence the expression of cTnT in cells when
subjected to myogenic differentiation. Three Lin− BM-MSC passages
were used: early passage (EP: P0–P2), intermediate passage (IP: P8–
12), and late passage (LP: P20) utilizing AZA or LS treatment. EP cells
were very slow to proliferate, and the few cells that remained
attached were cTnT− after 3 weeks of AZA or LS differentiation
treatment. Differentiating IP cells were cTnT+ within 3 weeks of
treatment (AZA: 14±1%, LS: 12±2%, n=53 and 46, respectively)
while LP cells were cTnT− over the 3-week period of AZA or LS
treatment. Figs. S3A, B, and C illustrate cTnT staining results of EP, IP,
and LP cells after LS differentiation treatment.
Since it has been demonstrated that Sca-1+ cells possess stem-
progenitor properties [17,18] and that CD117+ cells have the
potential to differentiate into a cardiac lineage [12], we used FACS
analysis to evaluate the amount of CD117/Sca-1 initially present on
EP, IP, and LP. The results indicated that approximately 10% of EP cells
were positive for CD117/Sca-1, whereas IPs exhibited approximately
1% of CD117/Sca-1+, and LPs only 0.01% of CD117/Sca-1+ cells; Figs.
S2A, B, and C show the FACS results of EP, IP, and LP, respectively.
3.2. CD117/Sca-1 enrichment and differentiation media
In our second series of experiments, we enriched both EP and IP
cells for CD117/Sca-1. EP cells were not adherent following
enrichment. Although our FACS results indicated that EP cells have
the highest number of CD117/Sca-1+ cells, their differentiationmight
be attenuated due to their low proliferation rate and attachment. To
further evaluate the differentiation potential of murine BM-MSC, we
therefore focused on the IP cells in the remaining series of
experiments.
To improve the percentage of cTnT-positive cells, we enriched
IP cells for CD117/Sca-1 and used the five differentiation con-
ditions described in the Materials and methods section (see also
Fig. S1). IP Lin−, BM-MSCs were enriched for CD117/Sca-1 at passage
8, seeded and then cultured with differentiation media until passage
10. By passage 10, these cells were 40% CD117+ and 99% Sca-1+ as
shown in Figs. S2D and E. IP CD117/Sca-1+ cells and IP control (non-
enriched), cells were cultured for differentiation for up to 21 days in
different combinations of AZA or LS. Fig. 1 provides a summary of the
overall series of experiments performed based on cell passage and
enrichment for CD117/Sca-1. Cell counts of microscopic fields of these
differentiated cells revealed that the enriched cells had 39±3% and
28±2% cTnT-positive expression compared to the non-enriched
control cells which had 14±1% and 12±2% after treatment with AZA
and LS, respectively, as shown in Fig. 2. A magnification of IP cTnT+
cell staining is shown in Fig. S4. Separately, IP CD117/Sca-1+ cells that
were treated with control culture medium (MEM and 5% FBS) only
exhibited 18±3% cTnT-positive cells, significantly less than in AZA or
LS-treated cultures (see Fig. S5). These results support the hypothesis
that CD117/Sca-1 enrichment of murine BM-MSC increases their
differentiation potential in specific media. The percent of cTnT+ cells
in the AZA+0% and 5% FBS groups were expressed as a ratio of the
AZA+2% FBS group used in our experiments. There was no difference
between AZAwith 0% FBS and AZAwith 2% FBS. AZAwith 5% FBS had a
significantly lower ratio of cTnT+ cells compared to the AZA +2% FBS
group (Fig. S6). Thus, we concluded AZA did not significantly improve
cTnT expression compared to 2% FBS alone but that serum levels
above 2% in the differentiating media significantly decreased the
expression of cTnT.
3.3. Temporal changes in expression of cTnT and BM-MSC morphology
To determine how differentiated BM-MSC change in size over
time, we fixed IP CD117/Sca-1+ cells differentiated in LS at different
intervals of time in culture. Figs. 3A–D illustrate representative
immunofluorescent images of cTnT staining observed on day 5, day
9, day 15, and day 21, respectively. Fig. 3E shows the area growth of
the cTnT-positive cells relative to day 5. It can be seen that there was
near zero increase in the area growth of the cells between day 5 and
day 15; however, there was a 1.83±0.21-fold increase in the cell area
between day 15 and day 21. These results suggest that the maturation
process of differentiated cTnT+ cells includes a period of cell area
expansion after 15 days in culture.
3.4. Temporal changes in intracellular Ca2+ transients
It has been previously reported that differentiating stem cell
derived cardiomyocytes early on exhibit spontaneous oscillations in
their intracellular Ca2+ concentration [16]. To determine if LS
differentiated IP CD117/Sca-1+ cells exhibited the same properties,
we monitored the cells [Ca2+]i with laser scanning confocal
microscopy. By day 12, cells exhibited intermittent transients with
short durations (see Fig. S8), whereas by day 14, the recorded
transients were consistent in rhythm and duration. We chose day 14
as our baseline and recorded confocal line scans again at days 19 and
29 of differentiation and evaluated their characteristics to determine
temporal changes in the intracellular Ca2+ transients. Figs. 4A and B
show representative line scans at day 14 and day 29. Analyses of
spontaneous intracellular Ca2+ transients show a decrease in the
Fig. 1. Description of first and second series of differentiation experiments: In the first experiment (EXP1), only IP cells expressed cTnT. In the second experiment (EXP2) following
CD117/Sca-1 enrichment, EP cells did not adhere and LP cells contained negligible CD117/Sca-1+ cells. Only IP cells were adherent and contained CD117/Sca-1+ cells and thus were
used for the remaining experiments.
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transient duration at 50% amplitude (TD50) over time. Fig. 4C shows
that the average TD50 was 1.17±0.11 s by day 14 compared to 0.66±
0.08 s by day 19 and 0.46±0.02 s by day 29. Similarly, Fig. 4D shows
that there was a decrease in transient duration at 90% (TD90) for the
same time periods; the average TD90 was 2.12±0.24 s, 1.15±0.12 s,
and 0.86±0.04 s for days 14, 19 and 29, respectively. Conversely, Fig.
4E shows that there was an increase in the average Ca2+ transient
frequency resulting in 0.62±0.08, 1.08±0.12, and 1.14±0.06 Hz for
days 14, 19 and 29, respectively. The number of cells and the
corresponding cycles analyzed were (10, 42), (7, 27), and (9, 76) for
days 14, 19, and 29, respectively.
Cells used for line scan Ca2+ transient measurements were fixed
and stained for cTnT and when possible the same cell was identified
on the slide for both measurements. Fig. 5 shows an example of a cell
with spontaneous Ca2+ transients stained positive for cTnT. These
data support the hypothesis that spontaneous Ca2+ oscillations
originate from cells exhibiting a cardiac lineage.
3.5. cTnT expression is enhanced after DHPR-α2 enrichment
DHPR-α2 is a membrane protein present in cardiac as well as
skeletal and neuronal cells. The expression of L-type Ca2+ channels is
an early event in the development of cardiacmyocytes [19]. To further
increase the number of cTnT-positive cells in our in vitro differenti-
ation studies, we proposed to include a DHPR-α2-positive selection
step as a second enrichment process, thus eliminating most non-
myogenic cells. This step was performed at day 26, after the cells had
differentiated into a cardiac muscle lineage (cTnT positive). Fig. 6A
Fig. 2. Immunofluorescence from cTnT stained IP CD117/Sca-1-enriched cells compared to IP unenriched (control) cells cultured for up to 21 days: (A) cTnT staining of control cells
treated with LS. (B) cTnT staining of CD117/Sca-1+ cells treated with LS. (C) cTnT staining of control cells treated with AZA. (D) cTnT staining of CD117/Sca-1+ cells treated with
AZA. (E) Mean cTnT-positive cells for enriched and control fractions cultured in AZA or LS. The number of sampled fields, n, from left to right was 31, 53, 33, and 46, respectively.
Values represent mean±SEM, and significant differences are ⁎pb0.05. There was no significant difference between the two enriched groups treated with AZA or LS.
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illustrates the PCR results of the IP CD117/Sca-1-enriched cells during
differentiation. These data demonstrate that amplicons for several
cardiac-specific and developmental genes are observed during the
early stage of differentiation. DHPR-α2 is also observed during
differentiation and suggests that this transmembrane subunit of the
L-type calcium channel is expressed commensurate with the cardiac-
specific genes. We noted that there was a doublet amplicon for the
DHPR-α2 subunit in our RT-PCR analysis. The primers used for the
PCR did not distinguish between cardiac and skeletal muscle forms of
the subunit suggesting that myogenic development for both skeletal
and cardiac muscle probably occurred in our cultures. Fig. 6B shows
the results of DHPR-α2 staining of CD117/Sca-1+ cells after 20 days in
differentiating media and B shows the DHPR-α2 FACS analysis of
CD117/Sca-1-enriched cells for the same time period. After having
sorted the differentiated cells described in Fig. 6C, the cells were
replated and cultured inMEMwith 5% FBS and ITS, and the sorted cells
recovered and easily adhered to the plate within the first 24 h.
These DHPR-α2-enriched cells were cultured for an additional
30 days and fixed for immunofluorescent cTnT staining (Fig. 6D). Cell
counts show that there was a significant increase in the percent of
cTnT-positive cells 54±3% (n=45) for the DHPR-α2-enriched
compared to 28±2% (n=33) in the CD117/Sca-1-enriched and
12±2% (n=46) in the control cells shown in Fig. 6E. Our control
experiments (Fig. S7) show that if differentiated cells with 2% FBS
are kept in culture for 56 days or if they are lifted at day 26 and
replated for an additional 30 days, the level of cTnT expression is
unchanged but is still significantly lower than the cTnT expression
observed in DHPR-α2-enriched cells.
We observed spontaneous Ca2+ oscillations in the DHPR-α2+
cells and were able to identify spontaneous Ca2+ transients in cTnT-
positive cells. It is interesting to note that we were able to observe
spontaneous synchronized cycling and movement on some DHPR-α2
cultured plates 30 days after seeding. Supplemental Video 1 shows a
group of differentiated DHPR-α2-enriched cells in motion and
Fig. 3. Temporal expression of cTnT and changes in BM-MSC Morphology: Representative immunofluorescent images of cTnT staining observed in IP CD117/Sca-1-enriched cells
following differentiation treatment in LS. (A) Day 5, (B) Day 9, (C) Day 15, (D) Day 21. (E) cTnT+ cell area relative to Day 5. The average number of fields and the number of cells
imaged per field was (10, 17), (6, 20), (3, 33), and (4, 41) for days 5, 9, 15, and 21, respectively.
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spontaneously cycling Ca2+ and Fig. S10 shows positive cTnT
staining of the same moving cells. In addition, Video-2 shows
another group of differentiated DHPR-α2-enriched cells in motion
after stimulated with a 1-ms pulse of 80 V after 30 days in LS culture
(for viewing purposes, the video speed was increased compared to
actual time).
3.6. Intracellular Ca2+ transients in DHPR-α2-enriched cells
The L-type Ca2+ channel is activated by depolarizing voltage
change during the upstroke of the cardiac action potential. To
determine if the DHPR-α2 enrichment process and the replating
affected the functional performance of the cells, we measured their
intracellular Ca2+ transients 30 days after the enrichment. Cells
exhibited Ca2+ transients upon field stimulation supporting the
hypothesis that the DHPR-α2-enriched cells are electrically excitable
cells. We compared the spontaneous Ca2+ transients previously
recorded to frequency matched stimulated Ca2+ transients. Fig. 7
shows the results of the statistical analysis of spontaneous and
stimulated intracellular Ca2+ transients of CD117/Sca-1 and DHPR-
α2s-enriched cells after differentiation in LS and cultured for 30 days
in MEM+5%FBS and ITS media. The average TD50 was 0.57±0.05 s
for the spontaneously cycling cells and 0.43±0.02 s for the stimulated
cells. The average TD90 was 0.99±0.09 and 0.72±0.03 s for the
spontaneous and stimulated cells, respectively. The average TA
(ΔF/F0) was 3.44±0.4 and 2.84±0.3 for spontaneous and stimulated
cells, respectively. Ca2+ transient examples are given in Fig. S9.
Overall the Ca2+ transient duration compares well with those
described for embryonic mouse cardiomyocytes [16]. Fluo-4/AM-
loaded DHPR-α2-enriched BM-MSCs were also electrically stimulated
in culture and sequentially incubated with either 40 µM nifedipine to
specifically block the L-type Ca2+ channel or 100 µM cadmium to
block calcium entry via both the L-type and T-type Ca2+ channels. Our
data demonstrate (Fig. 8 and Supplemental Video 3) that some of the
differentiated and enriched cells were sensitive to the addition of
nifedipine, suggesting that BM-MSCs did develop functional L-type
Fig. 4. Confocal line scan images of IP CD117/Sca-1+ cells loaded with Fluo-4/AM showing spontaneous intracellular Ca2+ transients: (A) representative Ca2+ cycling by day 14 of
culture. (B) Representative Ca2+ cycling by day 29. See also Supplemental Video 1. (C–E) Intracellular Ca2+ transients of spontaneously cycling cells at days 14, 19, and 29 in LS
differentiating media: (C) transient duration at 50% amplitude (TD50). (D) Transient duration at 90% amplitude (TD90). (E) Mean Ca2+ transient frequency. The number of cells and
the corresponding cycles analyzed were (10, 42), (7, 27), and (9, 76) for days 14, 19, and 29, respectively. Values represent mean+SEM and significant differences are ⁎pb0.05.
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calcium channels while transients in other cells persisted. When
exposed to cadmium, all fluo-4/AM generated calcium transients
were abolished (Supplemental Video 4).
4. Discussion
We have demonstrated that cardiomyogenesis in adherent bone
marrow-derived Lin− cells is greatly enhanced when differentiation
is initiated in intermediate passage cells (P8–P12) in low serum
following enrichment for the stem cell markers CD117/Sca-1. The
percent of cells expressing cardiac-specific TnT was significantly
elevated compared to those previously reported for bone marrow-
derived mesenchymal cells [20]. Most strikingly, a large number of
these myogenic cells also displayed spontaneous calcium transients
by day 12 in culture and reduced transient amplitude durations
between days 14 and 29. This temporal change in calcium transients
also correlated with the most significant changes in cell morphology
(between days 15 and 21 in culture). CD117/Sca-1+ cells cultured in
differentiating media also expressed DHPR-α2 by day 15. When these
cells were further enriched for DHPR-α2 and re-seeded for an
additional 30 days in culture, the percent of cells expressing cTnT
doubled compared to CD117/Sca-1+ BM-MSC-enriched cells alone.
We observed that the number of cTnT+ cells did not increase when
we extended the time in culture for an additional 30 days without
DHPR-α2 enrichment. Similarly, lifting and replating the cells for an
additional 30 days in culture did not improve the expression of cTnT
of CD117/Sca-1+ cells. Therefore, we conclude that further enrich-
ment of cells for a muscle-specific protein (DHPR-α2) establishes a
culture of highly differentiated cells that are more likely to exhibit a
myogenic lineage. Previous studies demonstrate that induction of the
myogenic program can be initiated in bone marrow-derived
mesenchymal stem cells but this has been limited to changes in
protein expression [6-9,20-23] or studies in which expression of
muscle-specific proteins in MSC have been induced by TGF-β [6],
Wnt-mediated signaling [20], and co-culturing with cardiac myocytes
[10-13,22].
The protocol in the present study included an enrichment step after
Lin−BM-MSCwere in culture for an extendedperiod of time (P8–P12).
In contrast, enrichment for CD117/Sca-1+ at the time of bonemarrow
harvest results in a significant population of hematopoietic stem cells
that have been shown to lack myogenic potential [24-26]. Further-
more, CD117 expression decreases over time and passage in culture [2,
6] due either to decreased expression of the receptor or loss of non-
adherent cells with passage. We observed these same changes in both
our EP and LP cells. EP cells did not adhere well to the culture plate
containing our differentiation media and LP cells lost expression of
CD117/Sca-1 over time. Thus, we cannot conclude from our experi-
ments that passage number has an effect on the potential for CD117/
Sca-1+ cells to develop into a myogenic lineage.
Observations of differentiated cells revealed large growth areas
with tubular-shaped cell formation andmulti-nucleated cells together
with large growth areas of non-myogenic cells. Thus, after testing for
the presence of DHPR-α2 in the differentiated cultures, we reasoned
that further enrichment for DHPR-α2 protein might produce cultures
with higher myogenic potential than CD117/Sca-1-enriched cells
alone. This second enrichment step resulted in an increase in cTnT-
positive cells. We also noted that there was a doublet amplicon for the
DHPR-α2 subunit in our RT-PCR analysis. The primers used for the
PCR did not distinguish between cardiac and skeletal muscle forms of
the subunit suggesting that myogenic development for both skeletal
and cardiac muscle probably occurred in our cultures.
The presence of calcium channels and ionic currents in undiffer-
entiated bone marrow mesenchymal stem cells has been previously
reported [27,28]. We were able to identify a nifedipine-sensitive
isoform of the L-type Ca2+ channel in cells enriched for the CD117/
Sca-1 cell surface markers and demonstrated that differentiated cells
displayed spontaneous Ca2+ transients. This is the first observation, to
our knowledge, in which differentiated BM-MSC displayed persistent
Fig. 5. IP CD117/Sca-1+ cell differentiated with LS for 26 days: (A) Fluo-4/AM-loaded cell. (B) Line scan of intracellular Ca2+ transient of cell on (A) showing spontaneous changes in
[Ca]i. (C) After fixation and staining, cell on (A) was identified on the plate and verified to be cTnT+.
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Fig. 6.DHPR-α2 enrichment increased the percent of cTnT+ cells in LS differentiatingmedia: (A) RT-PCR analysis for gene expression evaluation of DHPR-α2, cTnT, cTnI, GATA-4, and
GAPDH of IP cells differentiated after day 5, day 15, day 20, and day 26, respectively. An adult heart was used for positive control. (B) DHPR-α2 staining of CD117/Sca-1+-enriched
cells after 20 days in differentiating media. (C) DHPR-α2 flow cytometry analysis of CD117/Sca-1+-enriched cells after 26 days in differentiating media. (D) Representative
immunofluorescent image of cTnT staining of IP CD117/Sca-1 and DHPR-α2-enriched cells. (E) Mean cTnT-positive cells 30 days after DHPR-α2 enrichment (n=45) compared to
control (n=46) and CD117/Sca-1+ (n=33) cells. Values represent mean±SEM, and significant differences are ⁎pb0.05.
Fig. 7. Intracellular Ca2+ transients of spontaneously cycling and stimulated cells after CD117/Sca-1 and DHPR-α2 enrichment in LS differentiating media. (A) Transient duration at
50% amplitude (TD50). (B) Transient duration at 90% amplitude (TD90). (C) Mean transient amplitude (TA, ΔF/F0). Values represent mean±SEM and significant differences are
⁎pb0.05. The number of cells and the corresponding cycles analyzed were (6, 32) and (5, 26). Refer to supplemental data for representative Ca2+ transient examples.
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and robust Ca2+ oscillations in a large percentage of BM-MSC cultured
in the absence of cardiomyocytes or cardiomyocyte-conditioned
media. Kawano et al. [28] demonstrated that undifferentiated
human mesenchymal stem cells displayed spontaneous Ca2+ oscilla-
tions but that the primary pathway of Ca2+ entry into the cell was
from voltage-independent Ca2+ channels which are found in non-
excitable cells.
We have demonstrated evidence of L-type Ca2+ channels, with our
observations of DHPR-α2 in enriched and differentiated BM-MSC.
Furthermore, our Ca2+ transients could be initiated by electrical
stimulation in cells enriched for the channel protein (Fig. S9). In
addition, we have demonstrated that a population of our DHPR-α2-
enriched cells has functional L-type Ca2+ channels because we were
able to inhibit the Ca2+ transients with application of nifedipine, a
specific L-type Ca2+ channel blocker. Taken together, these data
suggest that Ca2+ entry into cells in the present study could have been
directed by voltage-sensitive L-type Ca2+ channels, characteristic of
cells undergoing myogenic differentiation.
One of the most striking findings in our study is that the frequency
of the Ca2+ transients increased over time and that the transient
amplitude duration of CD117/Sca-1-enriched cells decreased from 14
to 29 days in culture. Evidence from studies in embryonic-derived
cardiomyocytes [16] and developing heart [19,29] suggests that as the
cardiomyocyte matures from neonatal to adult, Ca2+ entry, storage,
and release is altered by synthesis and maturation of SR-Ca2+ release
channels and voltage-sensitive channels. The change in Ca2+ kinetics
observed in our cells over time is consistent with the observed
changes in the maturing cardiomyocyte.
In conclusion, we found that differentiating media containing low
serum was equally effective in inducing cTnT expression and
spontaneous calcium transients compared to the DNA methyltrans-
ferase inhibitor, 5-azacytidine. In addition, cTnT expression and
spontaneous calcium transients in BM-MSC were more prevalent in
IP cells following CD117/Sca-1 enrichment compared to unenriched
Lin− cells and variability in the calcium transients decreased as length
of time in differentiating media increased. The increase in spontane-
ous calcium cycling frequency, decrease in transient duration with
time, and identification of enriched cells with functional L-type Ca2+
channels suggests a progressive maturation of the calcium regulatory
mechanisms of the cell and thus greater myogenic development.
Taken together, these data demonstrate that specific cell enrichment
steps and early cardiac lineage development in culture may improve
the potential of BM-MSC for regenerative therapy.
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